List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 935 studies with search of: cancer vaccine
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
Conditions: Prostate Cancer;   Bladder Cancer;   Non-Small Cell Lung Cancer;   Esophageal Cancer;   Sarcoma
Intervention: Biological: NY-ESO-1 plasmid DNA Cancer Vaccine
2 Active, not recruiting Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: HyperAcute-Lung Cancer Vaccine
3 Completed A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Biological: CG8123;   Drug: Cyclophosphamide
4 Active, not recruiting Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Condition: Breast Neoplasms
Interventions: Biological: Allogeneic GM-CSF-secreting breast cancer vaccine;   Drug: Trastuzumab;   Drug: Cyclophosphamide
5 Recruiting Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
6 Completed Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
Condition: Prostate Cancer
Intervention: Biological: Immunotherapy allogeneic GM-CSF secreting cellular vaccine
7 Recruiting Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
8 Recruiting Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Stimuvax;   Biological: Placebo
9 Not yet recruiting Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population
Condition: Non-small Cell Lung Cancer
Interventions: Biological: L-BLP25 or BLP25 liposome vaccine (Stimuvax);   Biological: Placebo
10 Completed Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Immunotherapy allogeneic GM-CSF secreting cellular vaccine
11 Recruiting Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease
Condition: Hormonal Refractory Prostate Cancer
Intervention: Biological: CV9103
12 Terminated Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma
Condition: Melanoma
Intervention: Biological: Melaxin (autologous dendritoma vaccine) and BCG
13 Active, not recruiting Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
Condition: Lung Cancer
Intervention: Biological: GVAX lung cancer vaccine
14 Recruiting Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Intervention: Biological: CV9201
15 Active, not recruiting The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Biological: Dendritic Cell Tumor Fusion Vaccine
16 Active, not recruiting Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: allogeneic GM-CSF-secreting breast cancer vaccine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride
17 Recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Biological: GVAX pancreatic cancer vaccine;   Drug: cyclophosphamide
18 Recruiting Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions
Condition: Cervical Cancer
Intervention:
19 Active, not recruiting GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
Condition: Prostate Cancer
Intervention: Biological: GM-CSF gene transduced allogeneic vaccine GVAX
20 Recruiting Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: allogeneic GM-CSF-secreting breast cancer vaccine;   Biological: trastuzumab;   Drug: cyclophosphamide;   Genetic: microarray analysis;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Procedure: biopsy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services